Table 3 Age differences in cardiac damage in patients with severe type of COVID-19
From: Cardiac damage in patients with the severe type of coronavirus disease 2019 (COVID-19)
Median (IQR) or N (%) | p valuea | ||
|---|---|---|---|
Age ≥ 60 y (n = 60) | Age < 60 y (n = 40) | ||
Female | 29 (48.3) | 15 (37.5) | 0.285 |
Comorbidities | 48 (80.0) | 21 (52.5) | 0.004 |
Hypertension | 29 (48.3) | 11 (27.5) | 0.037 |
Diabetes | 17 (28.3) | 4 (10.0) | 0.027 |
CVD | 9 (15.0) | 6 (15.0) | 1.000 |
Hyperlipidemia | 2 (3.3) | 0 | 0.515 |
hsTnI, pg/ml | 5.2 (2.2–12.8) | 1.9 (1.9–6.2) | 0.018 |
Increased (> 34.2) | 7 (12.7) | 3 (8.3) | 0.755 |
NTproBNP, pg/ml | 177.5 (97.5–369.5) | 55.5 (18.0–432.8) | 0.018 |
Increased# | 12 (20.0) | 10 (25.0) | 0.554 |